EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

DHODH Alleviates Heart Failure via the Modulation of CoQ-Related Ferroptotic Inhibition

Chen Wang, Chuchu Chen, Jiabin Zhou, Jiayu Shi, Hanrui Sun, Jingyu Li, Pengyang Gu, Xinglin Wang, Qi Lu, Shuai Wang

Frontiers in Bioscience-Landmark · 24.07.2024 · 29 (7)

DOI: 10.31083/j.fbl2907267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 24.07.2024. Verfasst von Chen Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical School, Nantong University, 226000 Nantong, Jiangsu, China. Hauptthemen laut MEDLINE: Heart Failure, Ubiquinone, Ferroptosis, Mice, Inbred C57BL. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Multicenter Clinical Collaborative Research Project of Affiliated Hospital of Nantong University, Affiliated Hospital of Nantong University Research Physician Development Fund, Postgraduate Research & Practice Innovation Program of Jiangsu Province in 2022.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Heart failure (HF) is a clinical syndrome that seriously endangers human health and quality of life as the terminal stage of cardiovascular diseases. Ferroptosis as a new iron-dependent programmed cell death mode that is closely related to the occurrence and development of cardiovascular diseases. Dihydroorotate dehydrogenase (DHODH) has been found to play a crucial role in inhibiting ferroptosis and improving mitochondrial function, and its expression can be upregulated by estradiol (E2). Recent studies have found that DHODH can inhibit ferroptosis by reducing coenzyme Q (CoQ) to CoQH2. Therefore, this study aims to explore the effect of up-regulation of DHODH on the pathological hypertrophy and fibrosis of heart failure and its mechanisms.

Methods

The mouse heart failure model was established by transverse aortic constriction (TAC), surgery in mice. Two days after the operation, a subcutaneous injection of E2 or the same volume of sesame oil was given for 8 weeks. Then, the left ventricular systolic function related indicators of mice were measured by echocardiography, and the degree of myocardial fibrosis of mice was detected by histological analysis; the expression levels of heart failure markers were detected by quantitative polymerase chain reaction (q-PCR) and western blot (WB) analysis; the morphological changes of mitochondria in cardiac cells of mice were observed by transmission electron microscopy. Cell model were established by stimulating with phenylephrine for 96 hours. Ferroptosis markers were detected by kits and WB analysis. Mitochondrial function was verified by a JC-1 fluorescent probe, and 2′,7′-Dichlorodihydrofluorescein diacetate (DCFH-DA) staining. The knockdown results were detected by WB analysis after transfection of small interfering RNA (siRNA) of CoQ. Fer-1 was added as a positive control to verify the ferroptosis-related changes of myocardial cells.

Results

In the animal model, we found that E2 treatment alleviates TAC-induced cardiac hypertrophy and fibrosis and suppresses cardiomyocyte ferroptosis by promotes DHODH upregulation in murine cardiomyocytes. In the cell model, DHODH upregulation protects against phenylephrine-induced cardiomyocytes with failure. However, the effect on up-regulating DHODH was inhibited by transfection to down-regulate CoQ expression.

Conclusions

The up-regulation of DHODH could effectively ameliorate the manifestations of heart failure such as myocardial hypertrophy and fibrosis in mice after TAC surgery, inhibit ferroptosis of cardiac myocytes, and ameliorate mitochondrial function. The mechanism involves CoQ-related biological processes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Heart FailureUbiquinoneFerroptosisMice, Inbred C57BLAnimalsMiceMaleOxidoreductases Acting on CH-CH Group DonorsFibrosisDisease Models, AnimalMyocytes, Cardiac

Stichwörter der Autor:innen

CoQdihydroorotate dehydrogenaseestradiolferroptosisheart failure

Substanzen

UbiquinoneOxidoreductases Acting on CH-CH Group Donors

Autor:innen und Institutionen

  • Medical School, Nantong University, 226000 Nantong, Jiangsu, China.
  • Department of Cardiology, Affiliated Hospital of Nantong University, 226000 Nantong, Jiangsu, China.

Förderung

  • Multicenter Clinical Collaborative Research Project of Affiliated Hospital of Nantong University
  • Affiliated Hospital of Nantong University Research Physician Development Fund
  • Postgraduate Research & Practice Innovation Program of Jiangsu Province in 2022

Zitieren

APA

Wang, C., Chen, C., Zhou, J., Shi, J., Sun, H., Li, J., Gu, P., Wang, X., Lu, Q., & Wang, S. (2024). DHODH Alleviates Heart Failure via the Modulation of CoQ-Related Ferroptotic Inhibition. Frontiers in Bioscience-Landmark, 29(7). https://doi.org/10.31083/j.fbl2907267

Vancouver

Wang C, Chen C, Zhou J, Shi J, Sun H, Li J, et al. DHODH Alleviates Heart Failure via the Modulation of CoQ-Related Ferroptotic Inhibition. Frontiers in Bioscience-Landmark. 2024;29(7). doi:10.31083/j.fbl2907267

BibTeX
@article{Wang2024,
  author = {Wang, Chen and Chen, Chuchu and Zhou, Jiabin and Shi, Jiayu and Sun, Hanrui and Li, Jingyu and Gu, Pengyang and Wang, Xinglin and Lu, Qi and Wang, Shuai},
  title = {DHODH Alleviates Heart Failure via the Modulation of CoQ-Related Ferroptotic Inhibition},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2024},
  volume = {29},
  number = {7},
  doi = {10.31083/j.fbl2907267}
}
Kostenlos starten →